Abstract
Many pregnant women, in the world, drink caffeine-containing beverages. Maternal caffeine consumption during pregnancy may have adverse effects on foetus but results are conflicting. Our goals were to estimate the prevalence of caffeine use in a cohort of French pregnant women using maternal self-reports and to evaluate the association between caffeine consumption during pregnancy and delivery and newborn characteristics. All pregnant women who gave birth in a large French urban area during a limited period of time were included (in total 724 mothers were included). Coffee, tea or cola consumption as well as pregnancy and neonate characteristics were analysed. The mean consumption of caffeine per day slightly decreased from the first to the third trimester of pregnancy: 587 caffeine users, with a consumption of caffeine of 59.2 ± 61.5 mg/day during the first trimester as compared to 577 consumers (54.3 ± 55.4 mg/day) during the third trimester, respectively. A significant decrease of neonates’ birth length was observed when mothers were using at least 100 mg/day (or two cups) of caffeine during the second and third trimesters but this difference was no longer significant after adjustment on potential confounding factors such as tobacco use. The potential existence of other confounders (e.g. poorer dietary habits or other lifestyle variables) that might also be associated with reduced birth length, may not be excluded. Caffeine use during pregnancy was associated with reduced birth length but this effect was no longer significant after adjustment on potential confounding variables.
Similar content being viewed by others
References
Heckman MA, Weil J, Gonzalez de Mejia E (2010) Caffeine (1,3,7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci 75(3):R77–87
Maslova E, Bhattacharya S, Lin SW, Michels KB (2010) Caffeine consumption during pregnancy and risk of preterm birth: a meta-analysis. Am J Clin Nutr 92:1120–1132
Grosso LM, Bracken MB (2005) Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy. Ann Epidemiol 15:460–466
Darakjian LI, Kaddoumi A (2019) Physiologically based pharmacokinetic/pharmacodynamic model for caffeine disposition in pregnancy. Mol Pharm 16:1340–1349
CARE Study Group (2008) Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study. BMJ 337:a2332
Sengpiel V, Elind E, Bacelis J, Nilsson S, Grove J, Myhre R, Haugen M, Meltzer HM, Alexander J, Jacobsson B (2013) Maternal caffeine intake during pregnancy is associated with birth weight but not with gestational length: results from a large prospective observational cohort study. BMC Med 11:42–10
Li J, Zhao H, Song JM, Zhang J, Tang YL, Xin CM (2015) A meta-analysis of risk of pregnancy loss and caffeine and coffee consumption during pregnancy. Int J Gynaecol Obstet 130(2):116–122
Voerman E, Jaddoe VW, Gishti O, Hofman A, Franco OH, Gaillard R (2016) Maternal caffeine intake during pregnancy, early growth, and body fat distribution at school age. Obesity (Silver Spring) 24(5):1170–1177
Papadopoulou E, Botton J, Brantsæter AL, Haugen M, Alexander J, Meltzer HM, Bacelis J, Elfvin A, Jacobsson B, Sengpiel V (2018) Maternal caffeine intake during pregnancy and childhood growth and overweight: results from a large Norwegian prospective observational cohort study. BMJ Open 8(3):e018895
Hvolgaard Mikkelsen S, Obel C, Olsen J, Niclasen J, Bech BH (2017) Maternal caffeine consumption during pregnancy and behavioral disorders in 11-year-old offspring: a Danish National Birth Cohort Study. J Pediatr 189:120–127
Peck JD, Leviton A, Cowan LD (2010) A review of the epidemiologic evidence concerning the reproductive health effects of caffeine consumption: a 2000–2009 update. Food Chem Toxicol 48:2549–2576
Brent RL, Christian MS, Diener RM (2011) Evaluation of the reproductive and developmental risks of caffeine. Birth Defects Res B Dev Reprod Toxicol 92:152–187
Loomans EM, Hofland L, van der Stelt O, van der Wal MF, Koot HM, van der Bergh BR, Vrijkotte TG (2012) Caffeine intake during pregnancy and risk of problem behavior in 5-to 6-year-old children. Pediatrics 130(2):e305–313
Pei L, Kang Y, Cheng Y, Yan H (2015) The association of maternal lifestyle with birth defects in Shaanxi Province, Northwest China. PLoS ONE 10(9):e0139452
Klebanoff MA, Keim SA (2015) Maternal caffeine intake during pregnancy and child cognition and behavior at 4 and 7 years of age. Am J Epidemiol 182(12):1023–1032
Galéra C, Bernard JY, van der Waerden J, Bouvard MP, Lioret S, Forhan A, De Agostini M, Melchior M, Heude B, EDEN Mother-Child Cohort Study Group (2016) Prenatal caffeine exposure and child IQ at age 5.5 years: the EDEN mother-child cohort. Biol Psychiatry 80(9):720–726
Doepker C, Franke K, Myers E, Goldberger JJ. Lieberman HR, O’Brien C, Peck J, Tenenbein M, Weaver C, Wikoff D (2018) Key findings and implications of a recent systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. Nutrients 10 (10):E1536
Greenwood DC, Alwan N, Boylan S, Cade JE, Charvill J, Chipps KC, Cooke MS, Dolby VA, Hay AW, Kassam S, Kirk SF, Konje JC, Potdar N, Shires S, Simpson N, Taub N, Thomas JD, Walker J, White KL, Wild CP (2010) Caffeine intake during pregnancy, late miscarriage and stillbirth. Eur J Epidemiol 25(4):275–280
Temple JL, Bernard C, Lipshultz SE, Czachor JD, Westphal JA, Mestre MA (2017) The safety of ingested caffeine: a comprehensive review. Front Psychiatry 26(8):80
Leviton A (2018) Biases inherent in studies of coffee consumption in early pregnancy and the risks of subsequent events. Nutrients 10(9):E1152
Jahanfar S, Jaafar SH (2013) Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes. Cochrane Database Syst Rev 6:006965
Lamy S, Hennart B, Houivet E, Dulaurent S, Delavenne H, Benichou J, Allorge D, Marret S, Thibaut F; Perinatal network of Upper-Normandy (2017) Assessment of tobacco, alcohol and cannabinoid metabolites in 645 meconium samples of newborns compared to maternal self-reports. J Psychiatr Res 90:86–93
Aagaard SK, Larsen A, Andreasen MF, Lesnikova I, Telving R, Vestergaard AL, Tørring N, Uldbjerg N, Bor P (2018) Prevalence of xenobiotic substances in first-trimester blood samples from Danish pregnant women: a cross-sectional study. BMJ Open 8(3):e018390
Chen L, Bell EM, Browne ML, Druschel CM, Romitti PA, National Birth Defects Prevention Study (2014) Exploring maternal patterns of dietary caffeine consumption before conception and during pregnancy. Matern Child Health J 18(10):2446–2455
Balat O, Balat A, Ugur MG, Pençe S (2003) The effect of smoking and caffeine on the fetus and placenta in pregnancy. Clin Exp Obstet Gynecol 30(1):57–59
Kjersgaard C, Arendt LH, Ernst A, Lindhard MS, Olsen J, Henriksen TB, Strandberg-Larsen K, Ramlau-Hansen CH (2018) Lifestyle in pregnancy and cryptorchidism in sons: a study within two large Danish birth cohorts. Clin Epidemiol 10:311–322
Wierzejska R, Jarosz M, Wojda B (2019) Caffeine intake during pregnancy and neonatal anthropometric parameters. Nutrients 11:806. https://doi.org/10.3390/nu11040806
Okubo H, Miyake Y, Tanaka K, Sasaki S, Hirota Y (2015) Maternal total caffeine intake, mainly from Japanese and Chinese tea, during pregnancy was associated with risk of preterm birth: the Osaka Maternal and Child Health Study. Nutr Res 35(4):309–316
Bakker R, Steegers EA, Obradov A, Raat H, Hofman A, Jaddoe VW (2010) Maternal caffeine intake from coffee and tea, fetal growth, and the risks of adverse birth outcomes: the Generation R Study. Am J Clin Nutr 91(6):1691–1698
Modzelewska D, Bellocco R, Elfvin A, Brantsæter AL, Meltzer HM, Jacobsson B, Sengpiel V (2019) Caffeine exposure during pregnancy, small for gestational age birth and neonatal outcome—results from the Norwegian Mother and Child Cohort Study. BMC Pregnancy Childbirth 19(1):80. https://doi.org/10.1186/s12884-019-2215-9
Hoyt AT, Browne M, Richardson S, Romitti P, Druschel C, National Birth Defects Prevention Study (2014) Maternal caffeine consumption and small for gestational age births: results from a population-based case-control study. Matern Child Health J 18(6):1540–1551
Kobayashi S, Sata F, Murata K, Saijo Y, Araki A, Mivyashita C, Itoh S, Minatoya M, Yamazaki K, Ait Barnai Y, Kishi R (2019) Dose-dependent associations between prenatal caffeine consumption and small for gestational age, preterm birth, and reduced birthweight in the Japan Environment and Children's Study. Paediatr Perinat Epidemiol 33(3):185–194
Chen LW, Fitzgerald R, Murrin CM, Mehegan J, Kelleher CC, Phillips CM (2018) Lifeways cross generation cohort study. Am J Clin Nutr 108(6):1301–1308
Mills JL, Holmes LB, Aarons JH, Simpson JL, Brown ZA, Jovanovic-Peterson LG, Conley MR, Graubard BI, Knopp RH, Metzger BE (1993) Moderate caffeine use and the risk of spontaneous abortion and intrauterine growth retardation. JAMA 269:593–597
Del Castillo N, Jiménez-Moleón JJ, Olmedo-Requena R, Martínez-Ruiz V, Bueno-Cavanillas A, Mozas J (2015) Perinatal outcomes of prematurity and birth weight according to maternal caffeine consumption. Nutr Hosp 32(6):2658–2664
Adams T, Kelsberg G, Safranek S (2016) Clinical inquiry: does caffeine intake during pregnancy affect birth weight? J Fam Pract 65(3):205–213
Greenwood DC, Thatcher NJ, Ye J, Garrard L, Keogh G, King LG, Cade JE (2014) Caffeine intake during pregnancy and adverse birth outcomes: a systematic review and dose-response meta-analysis. Eur J Epidemiol 29(10):725–734
Rhee J, Kim R, Kim Y, Tam M, Lai Y, Keum N, Oldenburg CE (2015) Maternal caffeine consumption during pregnancy and risk of low birth weight: a dose-response meta-analysis of observational studies. PLoS ONE 10(7):e0132334
Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J (2017) Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ 359:j5024
Lassi ZS, Imam AM, Dean SV, Bhutta ZA (2014) Preconception care: caffeine, smoking, alcohol, drugs and other environmental chemical/radiation exposure. Reprod Health 11(S3):S6
Gaskins AJ, Rich-Edwards JW, Williams PL, Toth TL, Missmer SA, Chavarro JE (2018) Pre-pregnancy caffeine and caffeinated beverage intake and risk of spontaneous abortion. Eur J Nutr 57(1):107–117
European Food Safety Authority (EFS) (2015) Scientific opinion on the safety of caffeine. EFSA J 13:4102
The American College of Obstetricians and Gynecologists Committee Opinion (2018) Moderate caffeine consumption during pregnancy. https://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Moderate-Caffeine-Consumption-During-Pregnancy
Acknowledgements
Mothers and children who participated in the study; the Perinatal network of Upper-Normandy coordinated by C. Levèque, L. Marpeau (MD, PhD Professor, Head of Department of Gynaecology-Obstetrics, Rouen University Hospital); P. Fournet (MD, Department of Gynaecology-Obstetrics, Belvédère Hospital); M. Durand-Réville (MD, Department of Gynaecology-Obstetrics, Mathilde Hospital); Association of Midwives of Upper-Normandie, INSERM CIC-CRB 1404 (A. Cailleux and J. Weber); FEDER (Fonds Européens pour le Développement Régional de Haute-Normandie); Fédération Rouennaise d’Addictologie (coordinator: F. Thibaut). This study was supported by: PHRC inter-régional 2008, MILDT-INSERM-INcA 2008, IREB 2009 and 2011 and FEDER (European Regional Development Fund of Upper-Normandy). This study was promoted by Rouen University Hospital. The authors thank the reviewers for their helpful comments on our manuscript.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
F Thibaut is Editor-in-Chief of Dialogues in Clinical Neurosciences (the journal receives a grant from Servier). Other authors declared no conflicts of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lamy, S., Houivet, E., Benichou, J. et al. Caffeine use during pregnancy: prevalence of use and newborn consequences in a cohort of French pregnant women. Eur Arch Psychiatry Clin Neurosci 271, 941–950 (2021). https://doi.org/10.1007/s00406-020-01105-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-020-01105-2